Blood tests could pave the way for distinguishing between Alzheimer’s, Parkinson’s and some dementias, aiding early treatment for brain diseases.

While Patients Suffer, DEA Manipulates Due Process to Cover Its Cannabis Crimes. The DEA blocking federally compliant ...

A research team at the Medical University of Vienna has developed a blood test that allows the identification of individuals at risk for developing multiple sclerosis (MS) with a high degree of ...

Replacing defective microglia can halt ALSP—a fatal neurodegenerative disease—in mice and humans, offering hope for broader brain therapies.

The National Multiple Sclerosis Society (NMSS) announced a number of new funding opportunities aimed to bolster MS research and training. Support originates both from the Society and outside entities.

People with multiple sclerosis (MS) often face higher unemployment rates. Understanding the available support can help you navigate employment and financial stability.

We initiate coverage on Axon with a Sell rating and $608 PT, citing valuation risk despite robust growth and execution. Axon’s premium multiple is vulnerable to structural macro headwinds—high ...

Axon share price has formed a triple-top chart pattern on the daily chart. This is one of the riskiest chart patterns in the market. The company has become highly overvalued.

Axon pointed to the Taser 10 system, the Axon Body 4 sensor, and various virtual-reality and drone equipment as particularly strong contributors to top-line gains.

Gov. Katie Hobbs signed a bill into law on Friday that will clear the way for the Axon Scottsdale development near Loop 101 and Hayden Road.

Discover how Axon's Walled Garden Ecosystem empowers security agencies with unique tech capabilities.